Guangzhou Improve Medical Instruments Co Ltd (300030):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Improve Medical Instruments Co Ltd (300030) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6532
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Improve Medical Instruments Co Ltd (Improve Medical) is a medical devices company that offers medical products, technologies, and services for clinical laboratory and clinical nursing. The company’s products include Improvacuter evacuated blood collection systems, Impromini capillary blood collection systems and Improswab microbiological transportation systems. It also provides Impronurse infusion pumps and syringe pumps, Iongx urine analysis systems, in vitro diagnostic reagents and optimal solutions. Improve Medical offers gel and clot activator tubes, liquid biopsy tubes, safety lancet, blood collection needles, microbiology transport swab, bio-safetydecapper, needle holders, sharps containers, specimen seal-ups and others. The company has its operations in China and the US. Improve Medical is headquartered in Guangzhou, China.

Guangzhou Improve Medical Instruments Co Ltd (300030) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Guangzhou Improve Medical Plans to Raise up to USD87.3 Million in Private Placement of Shares 10
Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares 11
Debt Offering 12
Guangzhou Improve Medical Instruments Raises USD43.6 Million in Public Offering of 5.65% Bonds Due 2022 12
Acquisition 13
Guangzhou Improve Medical to Sell 7% Stake in Shenzhen-Based Medical Technology Company to an Investment Company for USD1.1 Million 13
Guangzhou Improve Medical Instruments Co Ltd – Key Competitors 14
Guangzhou Improve Medical Instruments Co Ltd – Key Employees 15
Guangzhou Improve Medical Instruments Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Key Facts, 2017 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guangzhou Improve Medical Instruments Co Ltd, Deals By Market, 2012 to YTD 2018 8
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guangzhou Improve Medical Plans to Raise up to USD87.3 Million in Private Placement of Shares 10
Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares 11
Guangzhou Improve Medical Instruments Raises USD43.6 Million in Public Offering of 5.65% Bonds Due 2022 12
Guangzhou Improve Medical to Sell 7% Stake in Shenzhen-Based Medical Technology Company to an Investment Company for USD1.1 Million 13
Guangzhou Improve Medical Instruments Co Ltd, Key Competitors 14
Guangzhou Improve Medical Instruments Co Ltd, Key Employees 15

List of Figures
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guangzhou Improve Medical Instruments Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Improve Medical Instruments Co Ltd (300030):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Genentech, Inc.:戦略・SWOT・企業財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Iluka Resources Ltd:企業の戦略・SWOT・財務情報
    Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Peel Environmental Ltd:電力:M&Aディール及び事業提携情報
    Summary Peel Environmental Ltd (Peel Environmental), a subsidiary of Peel Holdings (Management) Ltd, is a developer of infrastructures for the waste, mineral and environmental technology sectors. The company offers reprocess and re-manufacturing of waste materials with the use of energy. Its service …
  • Senomyx Inc (SNMX):企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • COSCO SHIPPING Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    COSCO SHIPPING Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary COSCO SHIPPING Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Netsmart Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Netsmart Technologies Inc (Netsmart) is a subsidiary of GI Partner, is a provider of enterprise software solutions for health and human services providers and payers. It provides on-demand and on-premise software solutions to automate major financial, clinical and management processes to its …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kelda Group Ltd:企業の戦略・SWOT・財務情報
    Kelda Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Kelda Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Russian Standard Bank:企業の戦略・SWOT・財務情報
    Russian Standard Bank - Strategy, SWOT and Corporate Finance Report Summary Russian Standard Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rheinmetall AG (RHM):企業の財務・戦略的SWOT分析
    Rheinmetall AG (RHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Stagecoach Group plc:企業の戦略・SWOT・財務情報
    Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report Summary Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Siamab Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Siamab Therapeutics Inc (Siamab Therapeutics), formerly Sialix Inc, is a biopharmaceutical company that focuses on the development of novel medicines targeting cancer-specific carbohydrate antigens. Its ST1 program targets a tumor associated carbohydrate antigen present in solid tumors. Siam …
  • Scientific Industries Inc (SCND):企業の財務・戦略的SWOT分析
    Summary Scientific Industries Inc (Scientific Industries) is a medical device company that designs and manufactures mixer, shaker and other laboratory products. The company’s product includes vortex mixers and shakers, rotators, rockers and incubators, magnetic stirrers, laboratory balances, force g …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆